AtriCure (ATRC)
AtriCure Key Statistics
Pro Data ExportCurrent Valuation
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | 72.97% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | -9.27% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 2.802 |
| Debt to Equity Ratio | 0.6768 |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | 5.76% |
| Year to Date Stock Returns | -19.01% |
| 1 Year Stock Returns | -36.87% |
| 3 Year Stock Returns | 251.2% |
| 52 Week High | 14.84 |
| 52 Week Low | 7.87 |
Income Statement
| Revenues TTM | 66.24M |
| Revenue Per Share TTM | 4.020 |
| Revenue Growth | 11.76% |
| Gross Profit TTM | 47.86M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | -5.802M |
| Earnings Per Share TTM | -0.37 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | 1.958M |
| Cash Financing TTM | 3.953M |
| Cash Operations TTM | -2.198M |
| Capital Expenditures | 0.638M |
Share Statistics
| Shares Outstanding | 16.48M |
Balance Sheet
| Cash and ST Investments | 15.29M |
| Total Assets | 36.59M |
| Liabilities | 21.94M |
| Book Value | 14.65M |
| Book Value per Share | 0.8891 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 9.917M |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these ATRC related companies
ATRC News
Listen to $ATRC Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3eG8
about 24 days ago by earningscast
about 24 days ago by earningscast
$ATRC filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Kwl
about 44 days ago by MarketBrief
about 44 days ago by MarketBrief
Leerink Swann Starts AtriCure Inc. (ATRC) at Outperform; Positive Sales Growth Inflection Point
Mar 20, 7:14AM Street Insider
Mar 20, 7:14AM Street Insider
Listen to $ATRC Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2a3D
about 90 days ago by earningscast
about 90 days ago by earningscast
AtriCure to Announce Fourth Quarter and Full Year 2011 Financial Results
Feb 21, 3:00PM Business Wire
Feb 21, 3:00PM Business Wire
Canaccord Genuity Reiterates a 'Buy' on AtriCure (ATRC); ATRC Has Productive STS
Feb 02, 9:36AM Street Insider
Feb 02, 9:36AM Street Insider
$ATRC Ablation System Receives FDA Approval for the Treatment of Atrial Fibrillation
about 163 days ago by Benzinga
about 163 days ago by Benzinga
Listen to $ATRC at piper jaffray health care conference - live at 10:00 AM, ondemand after - http://stks.co/1Jy5
about 179 days ago by earningscast
about 179 days ago by earningscast
$ATRC up 24.2%. Panel Recommends FDA Approval for Atrial Fibrillation Treatment
about 213 days ago by lewisgreen
about 213 days ago by lewisgreen
Great news for cheaper and less invasive treatment from $ATRC : http://on.wsj.com/oMFNyI
about 326 days ago by Mdhemp
about 326 days ago by Mdhemp
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ATRC | 8.99 | +0.58 | +6.90% | 148.16M |
| ATR | 50.61 | -0.45 | -0.88% | 3.366B |
| ATPG | 5.15 | +0.00 | +0.00% | 268.06M |
| ATO | 32.67 | -0.24 | -0.73% | 2.947B |
| ATNI | 32.59 | -0.04 | -0.12% | 503.52M |
| ATML | 7.29 | +0.12 | +1.67% | 3.287B |
| BABY | 11.22 | +0.02 | +0.18% | 330.32M |
| BAB | 29.70 | +0.01 | +0.03% | |
| BAA | 4.37 | +0.16 | +3.80% | 875.27M |
| BA | 70.00 | -1.39 | -1.95% | 52.35B |
